16 results

Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year follow-up in a subset of patients

Ziadni, Maisa; Chen, Abby L.; Krishnamurthy, Parthasarathy; More

PAIN Reports. 5(5):e851, September/October 2020.

Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control

Morales-Quezada, Leon; Mesia-Toledo, Ines; Estudillo-Guerra, Anayali; More

PAIN Reports. 5(4):e828, July/August 2020.

Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice

Feitosa, Geissy I.M.C.; Carvalho, Isabella F.; Coelho, Edivaldo B.S.; More

PAIN Reports. 4(6):e791, November/December 2019.

Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes

Papagianni, Aikaterini; Siedler, Gabriela; Sommer, Claudia; More

PAIN Reports. 3(2):e644, March/April 2018.

Acute pain management in patients with drug dependence syndrome

Quinlan, Jane; Cox, Felicia

PAIN Reports. 2(4):e611, July/August 2017.

Methylphenidate attenuates the response to cold pain but not to aversive auditory stimuli in healthy human: a double-blind randomized controlled study

Pud, Dorit; Broitman, Eelena; Hameed, Omar; More

PAIN Reports. 2(3):e593, May/June 2017.

Influence of opioid-related side effects on disability, mood, and opioid misuse risk among patients with chronic pain in primary care

Jamison, Robert N.; Dorado, Kathleen; Mei, Anna; More

PAIN Reports. 2(2):e589, March/April 2017.

Effects of local and spinal administrations of mu-opioids on postoperative pain in aged vs adult mice

Mecklenburg, Jennifer; Patil, Mayur J.; Koek, Wouter; More

PAIN Reports. 2(1):e584, January/February 2017.

TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study

Manitpisitkul, Prasarn; Brandt, Michael; Flores, Christopher M.; More

PAIN Reports. 1(4):e576, October 2016.